Physician profile
Beatriz Colon
NPI 1457313496
$1,579.51
in general payments reported to CMS, 2019-2025
14 companies · $311 in 2025
The $311 reported for 2025 was more than what 89% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24.59 · 2023: $1,244 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $926 · Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $926.26 |
| Food and Beverage | $628.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $1,243.89 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $311.03 | 2025 | |
| Genentech USA, INC. | $24.59 | 2020 |
11 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beatriz Colon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.